Rural Americans May Face Challenges Accessing Gene Therapy – Specialty Pharmacy Times
|
Rural Americans May Face Challenges Accessing Gene Therapy
Specialty Pharmacy Times The newly-approved gene therapies—tisagenlecleucel (Kymriah) for refractory B-cell precursor acute lymphoblastic leukemia and axicabtagene ciloleucel (Yescarta) for diffuse large B-cell lymphoma—offer significant benefits to patients with cancer … |
